GRI BIO INC(GRI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GRI GRI BIO INC

盘后交易 07-28 17:35:38 EDT

2.14

+0.15

+7.54%

盘后2.15

+0.00+0.23%

17:31 EDT

最高2.20	最低2.04	成交量13.90万
今开2.04	昨收1.99	日振幅7.84%
总市值534.32万	流通市值534.19万	总股本249.68万
成交额29.44万	换手率5.57%	流通股本249.62万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GRI","market":"US","secType":"STK","nameCN":"GRI BIO INC","latestPrice":2.14,"timestamp":1753732800000,"preClose":1.99,"halted":0,"volume":139032,"hourTrading":{"tag":"盘后","latestPrice":2.145,"preClose":2.14,"latestTime":"17:31 EDT","volume":5722,"amount":12233.2377488,"timestamp":1753738308580},"delay":0,"floatShares":2496197,"shares":2496800,"eps":-36.38047,"marketStatus":"盘后交易","change":0.15,"latestTime":"07-28 17:35:38 EDT","open":2.04,"high":2.1961,"low":2.04,"amount":294366.5864496,"amplitude":0.078442,"askPrice":2.15,"askSize":500,"bidPrice":2.1,"bidSize":169,"shortable":3,"etf":0,"ttmEps":-36.38047,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1753747200000},"marketStatusCode":4,"symbolChange":{"newSymbol":"RDOG","executeDate":"2020-01-02"},"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.99,"sharesOutstanding":1100000,"nav":47.93,"aum":52503274.57,"dividendRate":0.000467,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":2.05,"preClose":1.99,"latestTime":"09:22 EDT","volume":8437,"amount":17380.320400300003,"timestamp":1753708946185},"postHourTrading":{"tag":"盘后","latestPrice":2.145,"preClose":2.14,"latestTime":"17:31 EDT","volume":5722,"amount":12233.2377488,"timestamp":1753738308580},"volumeRatio":1.049621},"requestUrl":"/m/hq/s/GRI","defaultTab":"news","newsList":[{"id":"2551121615","title":"Gri Bio, Inc.盘中异动 股价大涨5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551121615","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551121615?lang=zh_cn&edition=full","pubTime":"2025-07-16 23:34","pubTimestamp":1752680093,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日23时34分，Gri Bio, Inc.股票出现异动，股价急速拉升5.56%。Gri Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.96%。Gri Bio, Inc.公司简介：GRI Bio Inc是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的疗法，这些疾病包括炎症、纤维化和自身免疫性疾病。GRI Bio的项目GRI-0621是一种小分子RAR-beta和gamma双重激动剂，能抑制人类NKT I细胞的活性，使免疫系统恢复到稳态。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716233453a6add1b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716233453a6add1b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","GRI"],"gpt_icon":0},{"id":"2551637187","title":"Gri Bio, Inc.盘中异动 早盘股价大涨5.72%报1.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551637187","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551637187?lang=zh_cn&edition=full","pubTime":"2025-07-14 23:01","pubTimestamp":1752505303,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日23时01分，Gri Bio, Inc.股票出现波动，股价快速上涨5.72%。Gri Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.19%。Gri Bio, Inc.公司简介：GRI Bio Inc是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的疗法，这些疾病包括炎症、纤维化和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071423014497a5d205&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071423014497a5d205&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","GRI","BK4139"],"gpt_icon":0},{"id":"2550639709","title":"Gri Bio, Inc.盘中异动 大幅拉升5.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550639709","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550639709?lang=zh_cn&edition=full","pubTime":"2025-07-12 01:42","pubTimestamp":1752255760,"startTime":"0","endTime":"0","summary":"北京时间2025年07月12日01时42分，Gri Bio, Inc.股票出现异动，股价快速上涨5.91%。Gri Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。Gri Bio, Inc.公司简介：GRI Bio Inc是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的疗法，这些疾病包括炎症、纤维化和自身免疫性疾病。GRI Bio的项目GRI-0621是一种小分子RAR-beta和gamma双重激动剂，能抑制人类NKT I细胞的活性，使免疫系统恢复到稳态。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071201424097a2966f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071201424097a2966f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRI","BK4007"],"gpt_icon":0},{"id":"2550626401","title":"Gri Bio, Inc.盘中异动 股价大跌5.42%报1.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550626401","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550626401?lang=zh_cn&edition=full","pubTime":"2025-07-10 22:04","pubTimestamp":1752156294,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日22时04分，Gri Bio, Inc.股票出现异动，股价急速下挫5.42%。截至发稿，该股报1.57美元/股，成交量3.9736万股，换手率1.69%，振幅4.82%。Gri Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Gri Bio, Inc.公司简介：GRI Bio Inc是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的疗法，这些疾病包括炎症、纤维化和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710220454a6a1cbeb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710220454a6a1cbeb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRI","BK4007","CGTX"],"gpt_icon":0},{"id":"2549852841","title":"Gri Bio, Inc.盘中异动 股价大涨5.44%报1.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549852841","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549852841?lang=zh_cn&edition=full","pubTime":"2025-07-08 21:37","pubTimestamp":1751981832,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日21时37分，Gri Bio, Inc.股票出现波动，股价急速拉升5.44%。截至发稿，该股报1.55美元/股，成交量2.6306万股，换手率1.12%，振幅3.33%。Gri Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Gri Bio, Inc.公司简介：GRI Bio Inc是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的疗法，这些疾病包括炎症、纤维化和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708213712979e638e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708213712979e638e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRI","BK4007","BK4139"],"gpt_icon":0},{"id":"2548842758","title":"Gri Bio, Inc.盘中异动 下午盘快速拉升5.42%报1.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548842758","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548842758?lang=zh_cn&edition=full","pubTime":"2025-07-02 03:18","pubTimestamp":1751397490,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日03时18分，Gri Bio, Inc.股票出现异动，股价大幅上涨5.42%。Gri Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.55%。Gri Bio, Inc.公司简介：GRI Bio Inc是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的疗法，这些疾病包括炎症、纤维化和自身免疫性疾病。GRI Bio的项目GRI-0621是一种小分子RAR-beta和gamma双重激动剂，能抑制人类NKT I细胞的活性，使免疫系统恢复到稳态。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507020318119532ea3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507020318119532ea3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","GRI"],"gpt_icon":0},{"id":"2548616014","title":"Gri Bio, Inc.盘中异动 下午盘大幅拉升5.93%报1.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548616014","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548616014?lang=zh_cn&edition=full","pubTime":"2025-07-01 01:26","pubTimestamp":1751304402,"startTime":"0","endTime":"0","summary":"北京时间2025年07月01日01时26分，Gri Bio, Inc.股票出现异动，股价快速拉升5.93%。截至发稿，该股报1.35美元/股，成交量2.7961万股，换手率1.19%，振幅3.15%。Gri Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。Gri Bio, Inc.公司简介：GRI Bio Inc是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的疗法，这些疾病包括炎症、纤维化和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070101264295318250&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070101264295318250&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","GRI"],"gpt_icon":0},{"id":"2546739172","title":"Gri Bio, Inc.盘中异动 股价大跌5.19%报1.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546739172","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546739172?lang=zh_cn&edition=full","pubTime":"2025-06-26 21:46","pubTimestamp":1750945611,"startTime":"0","endTime":"0","summary":"北京时间2025年06月26日21时46分，Gri Bio, Inc.股票出现异动，股价快速下挫5.19%。截至发稿，该股报1.28美元/股，成交量7.8756万股，换手率3.36%，振幅5.93%。Gri Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Gri Bio, Inc.公司简介：GRI Bio Inc是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的疗法，这些疾病包括炎症、纤维化和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626214652979002d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626214652979002d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRI","BK4007"],"gpt_icon":0},{"id":"2546230469","title":"Gri Bio, Inc.盘中异动 快速拉升5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546230469","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546230469?lang=zh_cn&edition=full","pubTime":"2025-06-25 02:55","pubTimestamp":1750791343,"startTime":"0","endTime":"0","summary":"北京时间2025年06月25日02时55分，Gri Bio, Inc.股票出现波动，股价急速上涨5.33%。Gri Bio, Inc.股票所在的生物技术行业中，整体涨幅为2.07%。Gri Bio, Inc.公司简介：GRI Bio Inc是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的疗法，这些疾病包括炎症、纤维化和自身免疫性疾病。GRI Bio的项目GRI-0621是一种小分子RAR-beta和gamma双重激动剂，能抑制人类NKT I细胞的活性，使免疫系统恢复到稳态。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506250255439529f418&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506250255439529f418&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRI","BK4139","BK4007"],"gpt_icon":0},{"id":"2543544665","title":"Gri Bio, Inc.盘中异动 股价大涨5.30%报1.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543544665","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543544665?lang=zh_cn&edition=full","pubTime":"2025-06-13 03:01","pubTimestamp":1749754879,"startTime":"0","endTime":"0","summary":"北京时间2025年06月13日03时01分，Gri Bio, Inc.股票出现波动，股价快速拉升5.30%。截至发稿，该股报1.39美元/股，成交量7.5068万股，换手率3.20%，振幅5.30%。Gri Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。Gri Bio, Inc.公司简介：GRI Bio Inc是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的疗法，这些疾病包括炎症、纤维化和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613030119a4a5bc4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613030119a4a5bc4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRI","BK4007","BK4139"],"gpt_icon":0},{"id":"2542533744","title":"Gri Bio, Inc.盘中异动 快速上涨5.04%报1.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542533744","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542533744?lang=zh_cn&edition=full","pubTime":"2025-06-11 22:45","pubTimestamp":1749653126,"startTime":"0","endTime":"0","summary":"北京时间2025年06月11日22时45分，Gri Bio, Inc.股票出现波动，股价大幅上涨5.04%。Gri Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Gri Bio, Inc.公司简介：GRI Bio Inc是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的疗法，这些疾病包括炎症、纤维化和自身免疫性疾病。GRI Bio的项目GRI-0621是一种小分子RAR-beta和gamma双重激动剂，能抑制人类NKT I细胞的活性，使免疫系统恢复到稳态。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506112245279517fc10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506112245279517fc10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRI","BK4007"],"gpt_icon":0},{"id":"2542334787","title":"Gri Bio, Inc.盘中异动 大幅跳水5.07%报1.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542334787","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542334787?lang=zh_cn&edition=full","pubTime":"2025-06-10 02:34","pubTimestamp":1749494094,"startTime":"0","endTime":"0","summary":"北京时间2025年06月10日02时34分，Gri Bio, Inc.股票出现波动，股价大幅下跌5.07%。Gri Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.35%。Gri Bio, Inc.公司简介：GRI Bio Inc是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的疗法，这些疾病包括炎症、纤维化和自身免疫性疾病。GRI Bio的项目GRI-0621是一种小分子RAR-beta和gamma双重激动剂，能抑制人类NKT I细胞的活性，使免疫系统恢复到稳态。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061002345497783061&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061002345497783061&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","GRI"],"gpt_icon":0},{"id":"2540062102","title":"Gri Bio, Inc.盘中异动 早盘股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540062102","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540062102?lang=zh_cn&edition=full","pubTime":"2025-06-04 22:34","pubTimestamp":1749047661,"startTime":"0","endTime":"0","summary":"北京时间2025年06月04日22时34分，Gri Bio, Inc.股票出现异动，股价大幅拉升5.19%。Gri Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.83%。Gri Bio, Inc.公司简介：GRI Bio Inc是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的疗法，这些疾病包括炎症、纤维化和自身免疫性疾病。GRI Bio的项目GRI-0621是一种小分子RAR-beta和gamma双重激动剂，能抑制人类NKT I细胞的活性，使免疫系统恢复到稳态。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060422342197719d69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060422342197719d69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRI","BK4007"],"gpt_icon":0},{"id":"2540962967","title":"Gri Bio, Inc.盘中异动 大幅下跌7.78%报1.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540962967","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540962967?lang=zh_cn&edition=full","pubTime":"2025-06-02 21:55","pubTimestamp":1748872535,"startTime":"0","endTime":"0","summary":"北京时间2025年06月02日21时55分，Gri Bio, Inc.股票出现波动，股价快速跳水7.78%。Gri Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.43%。Gri Bio, Inc.公司简介：GRI Bio Inc是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的疗法，这些疾病包括炎症、纤维化和自身免疫性疾病。GRI Bio的项目GRI-0621是一种小分子RAR-beta和gamma双重激动剂，能抑制人类NKT I细胞的活性，使免疫系统恢复到稳态。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602215536950b9904&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602215536950b9904&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","GRI"],"gpt_icon":0},{"id":"2538460265","title":"Gri Bio, Inc.盘中异动 早盘急速上涨5.83%报1.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2538460265","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538460265?lang=zh_cn&edition=full","pubTime":"2025-05-27 23:01","pubTimestamp":1748358117,"startTime":"0","endTime":"0","summary":"北京时间2025年05月27日23时01分，Gri Bio, Inc.股票出现异动，股价大幅上涨5.83%。Gri Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.15%。Gri Bio, Inc.公司简介：GRI Bio Inc是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的疗法，这些疾病包括炎症、纤维化和自身免疫性疾病。该信息摘要如下：Ascendiant Capital：维持GRI Bio评级，由买入调整至买入评级, 目标价由40.00美元调整至34.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527230157aa2c9a52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527230157aa2c9a52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRI","BK4139","BK4007"],"gpt_icon":0},{"id":"2538468313","title":"Ascendiant Capital：维持GRI Bio评级，由买入调整至买入评级, 目标价由40.00美元调整至34.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2538468313","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538468313?lang=zh_cn&edition=full","pubTime":"2025-05-27 18:34","pubTimestamp":1748342087,"startTime":"0","endTime":"0","summary":"Ascendiant Capital：维持GRI Bio(GRI.US)评级，由买入调整至买入评级, 目标价由40.00美元调整至34.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527183733976713e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527183733976713e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRI"],"gpt_icon":0},{"id":"2537944777","title":"Gri Bio, Inc.盘中异动 早盘股价大跌6.52%报1.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537944777","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537944777?lang=zh_cn&edition=full","pubTime":"2025-05-22 21:32","pubTimestamp":1747920767,"startTime":"0","endTime":"0","summary":"北京时间2025年05月22日21时32分，Gri Bio, Inc.股票出现异动，股价急速下跌6.52%。Gri Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。Gri Bio, Inc.公司简介：GRI Bio Inc是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的疗法，这些疾病包括炎症、纤维化和自身免疫性疾病。GRI Bio的项目GRI-0621是一种小分子RAR-beta和gamma双重激动剂，能抑制人类NKT I细胞的活性，使免疫系统恢复到稳态。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522213248a6e8f1ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522213248a6e8f1ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","GRI","BK4139"],"gpt_icon":0},{"id":"2537640233","title":"Gri Bio, Inc.盘中异动 下午盘急速上涨5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537640233","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537640233?lang=zh_cn&edition=full","pubTime":"2025-05-21 03:02","pubTimestamp":1747767766,"startTime":"0","endTime":"0","summary":"北京时间2025年05月21日03时02分，Gri Bio, Inc.股票出现波动，股价大幅上涨5.51%。Gri Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.48%。Gri Bio, Inc.公司简介：GRI Bio Inc是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的疗法，这些疾病包括炎症、纤维化和自身免疫性疾病。GRI Bio的项目GRI-0621是一种小分子RAR-beta和gamma双重激动剂，能抑制人类NKT I细胞的活性，使免疫系统恢复到稳态。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521030246aa2c9478&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521030246aa2c9478&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRI","NRXS","BK4082","BK4007","BK4139"],"gpt_icon":0},{"id":"2536628631","title":"Gri Bio, Inc.盘中异动 股价大跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536628631","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536628631?lang=zh_cn&edition=full","pubTime":"2025-05-20 01:17","pubTimestamp":1747675070,"startTime":"0","endTime":"0","summary":"北京时间2025年05月20日01时17分，Gri Bio, Inc.股票出现波动，股价急速跳水5.30%。Gri Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。Gri Bio, Inc.公司简介：GRI Bio Inc是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的疗法，这些疾病包括炎症、纤维化和自身免疫性疾病。GRI Bio的项目GRI-0621是一种小分子RAR-beta和gamma双重激动剂，能抑制人类NKT I细胞的活性，使免疫系统恢复到稳态。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520011750aa2c9313&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520011750aa2c9313&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRI","BK4007"],"gpt_icon":0},{"id":"2535223858","title":"Gri Bio, Inc.盘中异动 股价大跌5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535223858","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535223858?lang=zh_cn&edition=full","pubTime":"2025-05-15 22:43","pubTimestamp":1747320207,"startTime":"0","endTime":"0","summary":"北京时间2025年05月15日22时43分，Gri Bio, Inc.股票出现波动，股价大幅下跌5.44%。Gri Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。Gri Bio, Inc.公司简介：GRI Bio Inc是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的疗法，这些疾病包括炎症、纤维化和自身免疫性疾病。GRI Bio的项目GRI-0621是一种小分子RAR-beta和gamma双重激动剂，能抑制人类NKT I细胞的活性，使免疫系统恢复到稳态。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515224328a47fb7d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515224328a47fb7d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","GRI"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vallon-pharma.com","stockEarnings":[{"period":"1week","weight":0.0934},{"period":"1month","weight":0.4741},{"period":"3month","weight":0.0934},{"period":"6month","weight":-0.8096},{"period":"1year","weight":-0.9078},{"period":"ytd","weight":-0.8587}],"compareEarnings":[{"period":"1week","weight":0.0152},{"period":"1month","weight":0.0494},{"period":"3month","weight":0.157},{"period":"6month","weight":0.0479},{"period":"1year","weight":0.1833},{"period":"ytd","weight":0.0871}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"GRI Bio, Inc.于2018年1月11日根据特拉华州法律成立。该公司是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对与导致炎症、纤维化和自身免疫性疾病的失调免疫反应相关的严重疾病的创新疗法。该公司的目标是成为开发治疗这些疾病的疗法的行业领导者，并改善患有此类疾病的患者的生活。","exchange":"NASDAQ","name":"GRI BIO INC","nameEN":"GRI BIO INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GRI BIO INC(GRI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供GRI BIO INC(GRI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"GRI BIO INC,GRI,GRI BIO INC股票,GRI BIO INC股票老虎,GRI BIO INC股票老虎国际,GRI BIO INC行情,GRI BIO INC股票行情,GRI BIO INC股价,GRI BIO INC股市,GRI BIO INC股票价格,GRI BIO INC股票交易,GRI BIO INC股票购买,GRI BIO INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GRI BIO INC(GRI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供GRI BIO INC(GRI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}